Target intelligence / Profile preview

Nematode levamisole-sensitive nicotinic acetylcholine receptor 1 (L-AChR1)

Target
L-AChR1
Molecular classification
Ion channel, Receptor, Cys-loop ligand-gated ion channel
01

Overview

The Nematode levamisole-sensitive nicotinic acetylcholine receptor 1 (L-AChR1) is a heteropentameric, ligand-gated ion channel essential for neuromuscular coordination in parasitic nematodes (Boulin et al., 2011). It belongs to the Cys-loop superfamily of receptors and is typically composed of subunits such as UNC-38, UNC-63, UNC-29, and ACR-8, though the exact composition can vary between species (Boulin et al., 2011; Williamson et al., 2009). Located at the neuromuscular junction, L-AChR1 mediates excitatory signals from motor neurons to body wall muscles; its activation by acetylcholine triggers cation influx, leading to muscle depolarization and contraction (MSD Veterinary Manual). This receptor is a primary target for several classes of anthelmintic drugs, including imidazothiazoles like levamisole and tetrahydropyrimidines like pyrantel, which act as potent agonists (Boulin et al., 2011; Martin et al., 2004). These drugs cause prolonged channel opening, leading to persistent depolarization and spastic paralysis, which results in the parasite's detachment and expulsion from the host (MSD Veterinary Manual). However, the widespread use of these anthelmintics has led to the emergence of resistance, often characterized by genetic polymorphisms or altered expression of the receptor's constituent subunits (Neveu et al., 2010).

Other names
Levamisole-sensitive nicotinic acetylcholine receptorL-type nicotinic acetylcholine receptorHco-L-AChR1Levamisole receptor
02

Mechanism of action

Agonists (e.g., levamisole, pyrantel) induce persistent opening of the ligand-gated ion channel, leading to muscle depolarization, calcium influx, and spastic paralysis (Boulin et al., 2011; MSD Veterinary Manual). Antagonists (e.g., derquantel) block the receptor, preventing activation and leading to flaccid paralysis (Robertson et al., 2002).

03

Biological functions

Neuromuscular transmissionMuscle contractionLocomotionSignal transduction
04

Disease associations

InfectionHelminthiasis
05

Safety considerations

Anthelmintic resistance (Boulin et al., 2011)Cross-resistance between cholinergic agonists (Martin et al., 2004)Host-parasite selectivity (Wolstenholme, 2011)
06

Interacting drugs

Levamisole

6 more in the full profile.

07

Biomarkers

unc-38 gene mutationunc-63 gene mutationacr-8 gene mutationunc-29 gene mutationReduced subunit mRNA expression

Beyond the preview

Go deeper on Nematode levamisole-sensitive nicotinic acetylcholine receptor 1 (L-AChR1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nematode levamisole-sensitive nicotinic acetylcholine receptor 1 (L-AChR1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call